Control of hypertension and reversal of renal failure in scleroderma.
D058186:Acute Kidney Injury / Q000209:etiology / Q000628:therapy*; D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage / Q000627:therapeutic use; D006974:Hypertension, Malignant / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008914:Minoxidil / Q000008:administration & dosage / Q000627:therapeutic use; D009846:Oliguria / Q000209:etiology; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use; D006435:Renal Dialysis; D012595:Scleroderma, Systemic / Q000150:complications*; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D014665:Vasodilator Agents; D006830:Hydralazine; D008914:Minoxidil; D011433:Propranolol